share_log

Why It Might Not Make Sense To Buy Yunnan Baiyao Group Co.,Ltd (SZSE:000538) For Its Upcoming Dividend

Why It Might Not Make Sense To Buy Yunnan Baiyao Group Co.,Ltd (SZSE:000538) For Its Upcoming Dividend

爲什麼收購雲南白藥集團股份有限公司可能沒有意義, Ltd (SZSE: 000538) 即將派發的股息
Simply Wall St ·  05/05 20:51

Readers hoping to buy Yunnan Baiyao Group Co.,Ltd (SZSE:000538) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business day before the record date, which is the cut-off date for shareholders to be present on the company's books to be eligible for a dividend payment. The ex-dividend date is an important date to be aware of as any purchase of the stock made on or after this date might mean a late settlement that doesn't show on the record date. In other words, investors can purchase Yunnan Baiyao GroupLtd's shares before the 10th of May in order to be eligible for the dividend, which will be paid on the 10th of May.

讀者希望購買雲南白藥集團有限公司, Ltd(深圳證券交易所股票代碼:000538)的股息需要在短期內採取行動,因爲該股即將進行除息交易。除息日是記錄日期前的一個工作日,這是股東在公司賬簿上有資格獲得股息的截止日期。除息日是需要注意的重要日期,因爲在該日或之後購買的任何股票都可能意味着延遲結算,而結算日期並未顯示在記錄日期。換句話說,投資者可以在5月10日之前購買雲南白藥集團有限公司的股票,以便有資格獲得股息,股息將在5月10日支付。

The company's next dividend payment will be CN¥2.077 per share, and in the last 12 months, the company paid a total of CN¥2.08 per share. Based on the last year's worth of payments, Yunnan Baiyao GroupLtd stock has a trailing yield of around 3.6% on the current share price of CN¥57.25. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid. So we need to investigate whether Yunnan Baiyao GroupLtd can afford its dividend, and if the dividend could grow.

該公司的下一次股息將爲每股2.077元人民幣,在過去的12個月中,該公司共支付了每股2.08元人民幣。根據去年的支付額,雲南白藥集團有限公司股票的尾隨收益率約爲3.6%,而目前的股價爲57.25元人民幣。股息是長揸者投資回報的主要貢獻者,但前提是繼續支付股息。因此,我們需要調查雲南白藥集團有限公司能否負擔得起股息,以及股息是否可以增長。

Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Its dividend payout ratio is 87% of profit, which means the company is paying out a majority of its earnings. The relatively limited profit reinvestment could slow the rate of future earnings growth. We'd be worried about the risk of a drop in earnings. Yet cash flow is typically more important than profit for assessing dividend sustainability, so we should always check if the company generated enough cash to afford its dividend. The company paid out 100% of its free cash flow over the last year, which we think is outside the ideal range for most businesses. Companies usually need cash more than they need earnings - expenses don't pay themselves - so it's not great to see it paying out so much of its cash flow.

股息通常從公司收入中支付,因此,如果公司支付的股息超過其收入,則其股息被削減的風險通常更高。其股息支付率爲利潤的87%,這意味着該公司正在支付其大部分收益。相對有限的利潤再投資可能會減緩未來的收益增長速度。我們會擔心收益下降的風險。然而,在評估股息可持續性方面,現金流通常比利潤更重要,因此我們應始終檢查公司產生的現金是否足以支付股息。該公司去年支付了100%的自由現金流,我們認爲這超出了大多數企業的理想範圍。公司對現金的需求通常比他們需要的收入還要多——支出不能自己支付——因此,看到它支付這麼多的現金流並不是一件好事。

Yunnan Baiyao GroupLtd paid out less in dividends than it reported in profits, but unfortunately it didn't generate enough cash to cover the dividend. Were this to happen repeatedly, this would be a risk to Yunnan Baiyao GroupLtd's ability to maintain its dividend.

雲南白藥集團有限公司支付的股息少於其公佈的利潤,但不幸的是,它產生的現金不足以支付股息。如果這種情況反覆發生,這將對雲南白藥集團有限公司維持股息的能力構成風險。

Click here to see the company's payout ratio, plus analyst estimates of its future dividends.

點擊此處查看該公司的派息率,以及分析師對其未來股息的估計。

historic-dividend
SZSE:000538 Historic Dividend May 6th 2024
SZSE: 000538 歷史股息 2024 年 5 月 6 日

Have Earnings And Dividends Been Growing?

收益和股息一直在增長嗎?

Companies with consistently growing earnings per share generally make the best dividend stocks, as they usually find it easier to grow dividends per share. If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke. This is why it's a relief to see Yunnan Baiyao GroupLtd earnings per share are up 4.1% per annum over the last five years. Earnings have been growing somewhat, but we're concerned dividend payments consumed most of the company's cash flow over the past year.

每股收益持續增長的公司通常會生產最好的股息股票,因爲他們通常會發現增加每股股息更容易。如果收益下降而公司被迫削減股息,投資者可能會看到他們的投資價值化爲烏有。這就是爲什麼雲南白藥集團有限公司的每股收益在過去五年中每年增長4.1%令人欣慰的原因。收益有所增長,但我們擔心股息支付在過去一年中消耗了公司的大部分現金流。

Many investors will assess a company's dividend performance by evaluating how much the dividend payments have changed over time. In the past 10 years, Yunnan Baiyao GroupLtd has increased its dividend at approximately 24% a year on average. It's encouraging to see the company lifting dividends while earnings are growing, suggesting at least some corporate interest in rewarding shareholders.

許多投資者將通過評估股息支付在一段時間內發生了多大變化來評估公司的股息表現。在過去的10年中,雲南白藥集團有限公司的股息平均每年增加約24%。令人鼓舞的是,該公司在收益增長的同時提高了股息,這表明至少有一部分企業有興趣獎勵股東。

To Sum It Up

總結一下

Is Yunnan Baiyao GroupLtd an attractive dividend stock, or better left on the shelf? Yunnan Baiyao GroupLtd is paying out a reasonable percentage of its income and an uncomfortably high 100% of its cash flow as dividends. At least earnings per share have been growing steadily. With the way things are shaping up from a dividend perspective, we'd be inclined to steer clear of Yunnan Baiyao GroupLtd.

雲南白藥集團有限公司是有吸引力的股息股票,還是最好留在架子上?雲南白藥集團有限公司將收入的合理比例和高達100%的現金流作爲股息支付,令人不安。至少每股收益一直在穩步增長。從股息的角度來看,從形勢來看,我們傾向於避開雲南白藥集團有限公司。

Having said that, if you're looking at this stock without much concern for the dividend, you should still be familiar of the risks involved with Yunnan Baiyao GroupLtd. For example, we've found 1 warning sign for Yunnan Baiyao GroupLtd that we recommend you consider before investing in the business.

話雖如此,如果你在看這隻股票時不太擔心分紅,你仍然應該熟悉雲南白藥集團有限公司所涉及的風險。例如,我們發現了雲南白藥集團有限公司的一個警告信號,建議您在投資該業務之前考慮一下。

Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers.

通常,我們不建議只購買你看到的第一隻股息股票。以下是精選的具有強大股息支付能力的有趣股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論